| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2019 | GH Guardant Health, Inc. | Wiley Michael J | Chief Legal Officer | Sell | 80,000 | $65.96 | $5,276,554.59 | -6.8% | |
| May 8, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 907,000 | $2.11 | $1,914,575.54 | +0.1% | |
| May 8, 2019 | NEO Neogenomics Inc | Hipp Raymond R | Director | Sell | 150,000 | $22.41 | $3,361,880.25 | -27.6% | |
| May 6, 2019 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 115,000 | $25.26 | $2,904,714.58 | -44.5% | |
| May 6, 2019 | NEO Neogenomics Inc | Bonello William | Chief Strategy Officer | Sell | 7,200 | $23.53 | $169,416.00 | -51.7% | |
| May 3, 2019 | CDNA Caredx, Inc. | King Sasha77 | Chief Commercial Officer | Sell | 1,250 | $29.50 | $36,875.00 | -1.6% | |
| May 3, 2019 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 46,080 | $138.06 | $6,361,804.80 | -75.1% | |
| May 3, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,690 | $65.91 | $177,297.90 | -100% | |
| May 3, 2019 | NEO Neogenomics Inc | Cardoza George | President, Pharma Services | Sell | 151,676 | $22.82 | $3,461,246.32 | -33.5% | |
| May 3, 2019 | NEO Neogenomics Inc | Balliet Jennifer | VP And Chief Culture Officer | Sell | 30,000 | $22.74 | $682,200.00 | -33.7% | |
| May 2, 2019 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 119,347 | $22.14 | $2,642,342.58 | -23.4% | |
| May 1, 2019 | GH Guardant Health, Inc. | Lanman Richard B. | Chief Medical Officer | Sell | 3,842 | $64.84 | $249,126.58 | -1.4% | |
| May 1, 2019 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 131,340 | $65.32 | $8,579,185.50 | -50.7% | |
| Apr 30, 2019 | DHR Danaher Corp /de/ | Daniel William K | EVP | Sell | 10,772 | $132.05 | $1,422,388.74 | -7.7% | |
| Apr 30, 2019 | WST West Pharmaceutical Services Inc | Malone Daniel | Vice President &Controller | Sell | 4,458 | $123.03 | $548,477.10 | -13.3% | |
| Apr 30, 2019 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 50,713 | $273.21 | $13,855,538.03 | -2.3% | |
| Apr 29, 2019 | DHR Danaher Corp /de/ | Comas Daniel L | EVP | Sell | 30,000 | $131.00 | $3,930,000.00 | -18.3% | |
| Apr 29, 2019 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 186,960 | $131.31 | $24,548,908.27 | -17.8% | |
| Apr 29, 2019 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 22,738 | $130.89 | $2,976,229.72 | -21.6% | |
| Apr 25, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $65.11 | $35,029.18 | -100% | |
| Apr 24, 2019 | DHR Danaher Corp /de/ | Spoon Alan G55 | Director | Sell | 1,913 | $129.52 | $247,771.76 | -2.2% | |
| Apr 24, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 117,540 | $66.69 | $7,838,844.83 | -0.5% | |
| Apr 22, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 80,000 | $2.32 | $185,613.12 | - | |
| Apr 22, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 232,460 | $65.60 | $15,249,912.32 | -1.0% | |
| Apr 22, 2019 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 90,000 | $65.28 | $5,875,617.48 | -10.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.